Corrigendum to ‘Genomic sequencing identifies WNK2 as a driver in hepatocellular carcinoma and a risk factor for early recurrence’ [J Hepatol 71 (2019) 1152-63]

MLA

Shao-Lai Zhou, et al. “Corrigendum to ‘Genomic Sequencing Identifies WNK2 as a Driver in Hepatocellular Carcinoma and a Risk Factor for Early Recurrence’ [J Hepatol 71 (2019) 1152-63].” Journal of Hepatology, vol. 76, Apr. 2022, p. 990. EBSCOhost, https://doi.org/10.1016/j.jhep.2022.01.013.

APA

Shao-Lai Zhou, Zheng-Jun Zhou, Zhi-Qiang Hu, Cheng-Li Song, Yi-Jie Luo, Chu-Bin Luo, Hao-Yang Xin, Xin-Rong Yang, Ying-Hong Shi, Zheng Wang, Xiao-Wu Huang, Ya Cao, Jia Fan, & Jian Zhou. (2022). Corrigendum to ‘Genomic sequencing identifies WNK2 as a driver in hepatocellular carcinoma and a risk factor for early recurrence’ [J Hepatol 71 (2019) 1152-63]. Journal of Hepatology, 76, 990. https://doi.org/10.1016/j.jhep.2022.01.013

Chicago

Shao-Lai Zhou, Zheng-Jun Zhou, Zhi-Qiang Hu, Cheng-Li Song, Yi-Jie Luo, Chu-Bin Luo, Hao-Yang Xin, et al. 2022. “Corrigendum to ‘Genomic Sequencing Identifies WNK2 as a Driver in Hepatocellular Carcinoma and a Risk Factor for Early Recurrence’ [J Hepatol 71 (2019) 1152-63].” Journal of Hepatology 76 (April): 990. doi:10.1016/j.jhep.2022.01.013.